• United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 shares of common stock on Oct. 14, 2026.
• She exercised 9,500 stock options at $117.76 per share, leaving 233,410 options held indirectly through a trust.
• Sale prices ranged from $526.07 to $546 per share. The transactions left 324,443 common shares in the transacting trusts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000164), on October 15, 2026, and is solely responsible for the information contained therein.